2024 annual financial data
Kyntra Bio 2024 Operating margin
Kyntra Bio 2024 operating margin with verified reported values.
Direct answer
Operating margin was -507.8%.
Operating income was -150,416,000 USD and net income was -47,579,000 USD.
Operating cash flow was -137,999,000 USD.
Get free Kyntra Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 29,621,000 USD
- Operating income
- -150,416,000 USD
- Net income
- -47,579,000 USD
- Operating cash flow
- -137,999,000 USD